Nanobles

Nanobles is a science-driven health and wellness company focused on plant-derived bioactives, nanotechnology, and the Endocannabinoid System (ECS), which it refers to as the Master Regulator. Founded in 2020 and headquartered in Santa Barbara, California, the company operates an IP-heavy model, developing house brands and licensing proprietary formulations across nutraceutical, pharmaceutical, and agricultural sectors. Its portfolio includes the GENEVEX and PREVENT programs targeting oncology and ECS health, the Nano Terps line of terpene-based topicals, and the Plant Chat AI platform for plant medicine research. In 2025, Nanobles merged with the Global Cannabinoid Research Center (GCRC) to accelerate its R&D in cannabinoid science and thermodynamic delivery systems like Thermonoids. The company aims to bridge the gap between traditional plant wisdom and modern clinical standards through evidence-based formulations and disciplined quality systems.